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A method is described for the identification and relative quantification of proteomes using
accurate mass tags (AMT) generated by nLC-dual ESI-FT-ICR-MS on a 7T instrument in
conjunction with stable isotope labeling using 16O/18O ratios. AMTs were used for putative
peptide identification, followed by confirmation of peptide identity by tandem mass spectro-
metry. For a combined set of 58 tryptic peptides from bovine serum albumin (BSA) and human
transferrin, a mean mass measurement accuracy of 1.9 ppm0.94 ppm (CIM99%) was obtained.
This subset of tryptic peptides was used to measure 16O/18O ratios of 0.36  0.09 (CIM99%) for
BSA (  0.33) and 1.48  0.47 (CIM99%) for transferrin (  1.0) using a method for
calculating 16O/18O ratios from overlapping isotopic multiplets arising from mixtures of 16O,
18O1, and
18O2 labeled C-termini. The model amino acid averagine was used to calculate a
representative molecular formula for estimating and subtracting the contributions of naturally
occurring isotopes solely as a function of peptide molecular weight. The method was tested
against simulated composite 16O/18O spectra where peptide molecular weight, 16O/18O ratio,
18O1/
18O2 ratios, and number of sulfur atoms were varied. Relative errors of 20% or less were
incurred when the 16O/18O ratios were less than three, even for peptides where the number of
sulfur atoms was over- or under-estimated. These data demonstrate that for biomarker
discovery, it is advantageous to label the proteome representing the disease state with 18O; and
the method is not sensitive to variations in 18O1/
18O2 ratio. This approach allows a
comprehensive differentiation of expression levels and tentative identification via AMTs,
followed by targeted analysis of over- and under-expressed peptides using tandem mass
spectrometry, for applications such as the discovery of disease biomarkers. (J Am Soc Mass
Spectrom 2004, 15, 437–445) © 2004 American Society for Mass SpectrometryThe characterization of differences between theexpressed protein complement, or proteome, ofrelated biological states is a recurring, fundamen-
tal task at the center of many research programs in the
life sciences. The ability to detect and quantify signifi-
cant changes in protein expression levels is essential to
both discovery (e.g., identification of biomarkers) and
hypothesis-driven research. The analytical challenges
arise from the high degree of sample complexity and
wide dynamic range of proteins that are present in
tissues and biofluids. As a common example serum, the
most highly sampled biological fluid, has been esti-
mated to contain as many as 106 different proteins
present at concentrations ranging over 10 orders of
magnitude [1].
A variety of analytical approaches have been re-
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doi:10.1016/j.jasms.2003.11.016ported that utilize bottom-up proteomics and stable
isotope labeling to perform relative quantification of
proteins [2–6]. These methods can be broadly classified
as either (1) metabolic, where the isotope label is
incorporated during protein synthesis, (2) amino acid
specific, where the stable isotope label is applied only to
peptides containing a specific amino acid, such as
cysteines with the ICAT method, and (3) global labeling
methods where the label is applied to every peptide
within the complex mixture. Metabolic labeling is only
possible in a limited number of circumstances, while
amino acid specific methods such as ICAT have the
advantage of reducing sample complexity but have
disadvantages of discriminating against proteins with
low number of cysteines, and being cost-prohibitive
especially for matrices such as serum that have a high
total protein content where the majority of the total
protein content is comprised of a small number of
highly abundant proteins.
One method of global labeling inserts an isotopic
label via the molecule of water that is incorporated intor Inc. Received September 18, 2003
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proteases [4, 7–13]. By using H2
18O during proteolysis,
18O is incorporated into the carboxy-terminus of pep-
tides formed during proteolysis. Prior to its use for
relative quantification, the insertion of an 18O molecule
during proteolysis has been utilized to produce internal
standards for absolute quantification [9], identify C-
terminal peptides [8], distinguish y-type ions from
b-type ions in tandem mass spectrometry sequencing of
peptides [12, 14], and identify sites of N-linked glyco-
sylation after enzymatic removal of the glycans [13].
When using 18O for relative quantification of pro-
teomes, a proteome sample representing the control
state is digested in H2
16O, and the diseased state is
digested in the presence of H2
18O; subsequently, the two
samples are mixed. The relative abundances of 16O and
18O species for each tryptic peptide are used to quantify
the relative protein abundance between each proteome.
Differential labeling using 18O water results in over-
lapping isotope patterns where signal from the 18O label
is superimposed with naturally occurring isotopes from
the non-labeled sample. Typically, any response from
the 13C content of the unlabeled sample is subtracted
from the abundance of the isotope peak containing 18O
signal after identifying the peptide sequence (most
commonly by tandem mass spectrometry) and calculat-
ing its 13C contribution to the signal based upon the
empirical formula of the identified peptide. This limits
the quantification process to peptides that have been
identified, which is a significantly reduced subset of the
total number of isotope pairs present in a data set.
This report describes a method to decouple the
quantification process from peptide identification by
estimating the naturally occurring isotope component
solely from peptide molecular weight. The isotopic mul-
tiplets observed in 16O/18O labeling experiments are re-
duced into their three contributing components represent-
ing two biological states: A 16O component which
represents the control state, and the 18O1 and
18O2
components which are summed to represent the disease
state. The precision and accuracy of our approach are
reported and discussed for a model system using bo-
vine serum albumin (BSA) and human apotransferrin.
Experimental
Preparation of Samples
Bovine serum albumin (BSA), apo-transferrin, DTT, and
iodoacetamide were purchased from Sigma Chemical
(St. Louis, MO). Stock solutions of BSA and transferrin
were prepared at 5 mg/mL and 2 mg/mL, respectively,
in 100 mM ammonium bicarbonate, pH 7.0. For the
16O/18O labeling experiments, two samples were pre-
pared; the 16O sample consisted of 50 g each of BSA
and transferrin, the 18O sample consisted of 150 g of
BSA and 50 g of transferrin for an expected 16O/18O
ratio of 1:3 for BSA and 1:1 for transferrin. Each sample
was evaporated to dryness, resuspended in 50 L of 6M urea (in 50 mM ammonium bicarbonate, pH 8.4), and
sonicated for five min. The samples were reduced with
DTT for 30 min at 37 °C, and alkylated with iodoacet-
amide for 60 min at room temperature in the dark.
Reagents for reduction and alkylation were prepared in
16O water. After reduction and alkylation, the samples
were evaporated to dryness on a vacuum centrifuge.
Before proteolytic digestion, the two samples were
reconstituted in 150 L of deionized 16O water and 18O
water, respectively, using a vortex mixer and brief
sonication. 18O water (95% purity) was obtained from
ICON Stable Isotopes, Summit, NJ. The two samples
were digested overnight with TPCK-treated trypsin
(Promega, Madison, WI) at 37 °C, using an enzyme:
substrate ratio of 1:50 (w : w). Digestion was terminated
by the addition of 10 L of 1% formic acid/0.2%
heptafluorobutyric acid (HFBA) and samples were fro-
zen at 20 °C.
Nano-Scale Liquid Chromatography (nLC)
nLC was performed using a 24 cm long by 100 m i.d.
IntegraFrit column (NewObjective, Woburn, MA)
packed with Magic C18Aq, 5 m, 200 Å particles
(Michrom BioResources, Auburn, CA). Mobile phase A
was water/acetonitrile/n-propanol/formic acid (98/1/
1/0.2 by volume), while mobile phase B was acetoni-
trile/n-propanol/water/formic acid (80/10/10/0.2 by
volume). A nLC flow rate of 0.4 L/min was split from
HPLC pumps flowing at 20 L/min. A gradient from 0
to 50% B over 40 min was used. A reversed phase
pre-column (0.3 mm i.d. by 5 mm long, Dionex, Sunny-
vale, CA) was used to pre-concentrate and desalt sam-
ples within the sampling loop of a 10-port valve (VICI,
Houston, TX) prior to switching the valve to place the
precolumn in-line with the nano-scale column during
development of the gradient. The pre-column was also
packed with Magic C18Aq, 5 m, 200 Å.
nLC-Dual ESI-FTICR-MS Accurate Mass
Measurements
nLC-dual ESI-FTICR-MS accurate mass data were ob-
tained on an IonSpec FT-ICR mass spectrometer (Ion-
Spec, Irvine, CA) with a 7 tesla actively shielded mag-
net, and equipped with a dual sprayer nano-ESI source
compatible with coupling to LC that has been described
elsewhere [15]. This second generation dual ESI source,
building on our success with an earlier design [16, 17],
allowed faster (30 ms versus 300 ms) computer-con-
trolled switching between two independent spray emit-
ters, one spraying the nLC eluant, the other spraying a
solution containing 1 M each of bradykinin and glu-
cagon. This allowed for internal mass calibration of all
spectra since sample ions and mass calibrant ions were
in the ICR cell simultaneously. Each 1024 K word
transient was Fourier transformed to the frequency
domain after being zero-filled twice and processed with
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mass calibrated using the monoisotopic peaks from the
doubly charged ion of bradykinin (m/z 530.7898), and
the quadruply and triply charged ions of glucagon at
m/z 871.1612 and m/z 1161.2125, respectively.
nLC-Q-TOF-MS/MS Measurements
nLC-MS/MS measurements were performed on a Q-
TOF 2 mass spectrometer (Waters, Milford, MA) with
automatic selection of up to 4 precursor ions from every
MS survey scan. Tandem mass spectra were processed
by MassLynx software (version 3.5) and searched
against the NCBI non-redundant database (Feb. 03,
ftp.ncbi.nih.gov) using Sequest software (ThermoFinni-
gan, San Jose, CA).
Results and Discussion
In order to characterize the use of 16O/18O ion ratios as
a method for quantification of relative protein expres-
sion levels, two samples, hereafter referred to as the
light and heavy sample, were prepared for 16O/18O
labeling. Each sample contained known amounts of
BSA and transferrin. The two samples were digested
with trypsin as described in the Methods section using
H2
16O and H2
18O (95% purity), respectively. The ex-
pected relative abundances between the two samples
for the two proteins were 1:3 for BSA and 1 : 1 for
transferrin. The tryptic peptides were analyzed by nLC-
dual ESI-FT-ICR-MS for accurate mass measurements
of peptides and determination of 16O/18O ion ratios.
Peptides were identified on the basis of both accurate
mass tags (AMT) [18] from the 7T FT-ICR instrument
and tandem mass spectrometry data from the Q-TOF 2.
From the set of peptides from BSA and transferrin that
were identified by both techniques, a mean mass accu-
racy  the confidence interval of the mean at the 99%
confidence level (CIM99%) of 1.9 ppm  0.94 was
obtained from 60 measurements.
Figure 1a shows a portion of a FTICR mass spectrum
containing the triply charged ion at m/z 627.6459 from
the BSA tryptic peptide RPCFSALTPDETYVPK, (Mr 
1879.916). This peptide was measured with a mass
accuracy of 1.0 ppm using the dual ESI source and
internal mass calibration. The spectrum illustrates a
type of composite spectrum that is obtained from a
16O/18O labeling experiment. The isotopic peaks anno-
tated as A, A  2, and A  4 are the peaks used in
relative quantification. The non-annotated peaks are
primarily composed of 13C1 contributions related to the
annotated peaks.
The monoisotopic peak, labeled A, primarily repre-
sents the light sample, although a contribution to its
abundance originates from the heavy sample due to the
5% impurity of 16O present in 18O water when only
one oxygen has been exchanged (vide infra). The rela-
tive abundance of the A  2 peak is a composite of
signals arising from the heavy sample due to variableincorporation of one 18O atom(s), and a predictable
abundance arising from the naturally occurring iso-
topes (e.g., 13C, 34S) of the light sample.
Likewise, the signal at the A  4 peak is also a
composite, with contributions from three entities: (1)
From the heavy sample where two 18O atoms have been
incorporated, (2) from the heavy sample, as the natu-
rally occurring A  2 contribution from one 18O atom
incorporation, and finally (3) a contribution from the
light sample via its naturally occurring A  4 isotope.
The primary contributors to naturally occurring iso-
topes 2 and 4 mass units higher than the monoisotopic
signal are 13C2 and
34S, and 13C4,
13C2
34S, and 34S2,
respectively. For simplicity, we will refer to A  2 and
A  4 signals arising from naturally occurring isotopes
as the 13C2 and
13C4 responses.
Another complication to calculation of the 16O/18O
ratio comes from impurities of 16O present in 18O water.
The purity of 18O water used in this study was reported
by the vendor to be 95%. Assuming 95% purity, the
insertion of a water molecule that occurs during the
initial hydrolysis of a polypeptide bond will introduce a
5% response into the 16O channel from the heavy
sample, and reduce the 18O1 response by 5%.
The incorporation of two 18O atoms, resulting in a 4
da mass increase, has been widely reported and can be
desirable for more easily separating the light sample
from the heavy sample. Methods have been reported
for driving this enzyme-mediated oxygen substitution,
or EMOS, reaction toward incorporation of two 18O
atoms [19–21]. For this to happen, a tryptic peptide
must re-associate with the protease, where another
oxygen atom from water can be exchanged for one of
the two oxygens in the free carboxy terminus of the
peptide. Due to the resonance of the carboxyl oxygens
at pH 8, this second event has equal chances of replac-
ing the recently incorporated 18O or the other 16O atom.
Therefore, to accomplish a quantitative 4 da mass shift
(quantitative incorporation of two 18O atoms), multiple
EMOS events must occur for every tryptic peptide.
After the initial enzyme hydrolysis which generates
a 50:50 distribution of 16O and 18O for the two carboxyl
oxygens, four additional EMOS events would be ex-
pected to increase the probability that both oxygen
atoms had been exchanged to 97%. At that point the
overall distribution of 16O, 18O1, and
18O2 species within
the heavy sample would be limited by the purity of the
18O water. If that condition were met, then the contri-
bution to the 16O channel would be negligible: 0.25% as
described by (a  b)2, where a is the abundance of 16O
(0.05) and b is the abundance of 18O (0.95) in the H2
18O.
The term a2 represents the relative contribution to the
16O signal, 2ab represents the contribution to the 18O1
signal, and b2 represents the contribution to the 18O2
signal.
In our experience, given high sample complexity
(e.g., such as a tryptic digest of serum), together with
the variability in kinetics of re-association with the
enzyme for different peptide sequences, it is common to
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18O2.
Therefore, we applied a correction of 5% to the 16O and
18O1 ion abundances due to contribution by the heavy
sample to the 16O signal, and we define the absolute
abundances of the contributing components to the
16O/18O ratio as:
16O[A](0.0518O1) (1)
18O [A2]16O13C (0.0516O) (2)
Figure 1. (a) FTICR mass spectrum of a 16O/
peptide RPCFSALTPDETYVPK. The histogram
labeled species to the A, A  2, and A  4 isoto
A 4 relative abundance versus peptide molecu
calculated using the model amino acid averag
modeling software within MassLynx V4.0.1 218O2[A4]
18O1
13C2
16O18C4 (3)
Calculation of Naturally Occurring Isotope
Distributions for Peptides
The abundances of naturally occurring stable isotopes
are well characterized and algorithms for calculating
the relative abundances of these isotopes have been
reported [22, 23]. Corrections to 16O/18O ratios based
beled triply charged ion from the BSA tryptic
w the relative contributions from 16O and 18O
eaks. (b) Plot of naturally occurring A  2 and
eight. A 2 and A 4 relative abundances were
to generate chemical formulas for the isotope18O-la
s sho
pic p
lar w
ine
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relative quantification methods [4, 13]. However, all of
these methods are predicated on knowing the amino
acid sequence or composition, and using its chemical
formula to calculate the relative abundances of the
naturally occurring isotopes. This approach requires
peptide identification, primarily done from tandem
mass spectral data and database searching, before rela-
tive quantification can be performed.
We have developed a method that calculates the
relative abundances of naturally occurring stable iso-
topes solely as a function of peptide molecular weight.
Thus, relative quantification can be done without prior
knowledge of sequence. This offers the advantage of
allowing sample differentiation and putative peptide
identification, via relative quantification and AMTs,
independently of tandem mass spectrometry. Subse-
quently, tandem mass spectrometry can be performed
on a targeted subset of tryptic peptides to augment the
accurate mass tag for confident peptide identification.
The method uses the computational amino acid
averagine, described by Senko et al., that was derived
by calculating an average amino acid from all proteins
in the PIR database [24]. Averagine has a chemical
formula of C4.9384H7.7583N1.3577O1.4773S0.0417 and an aver-
age molecular weight of 111.1254 Da. Using averagine
as implemented in ICR-2LS [25], we generated a table of
molecular formulas and their respective monoisotopic
masses for a series of average chemical masses ranging
from 500–3000 Da. We used the isotope modeling
software in MassLynx version 4.0 to calculate theoreti-
cal abundances of the A  2 and A  4 ions relative to
A, and plotted relative ion abundance versus monoiso-
topic mass. These data were fit using a power function
to generate equations that describe the relative abun-
dances for the naturally occurring A 2 and A 4 ions
as a function of peptide molecular weight. The results of
this are shown in Figure 1b where the relative abun-
dance of the naturally occurring A  2 ion (A  2/A)
over an Mr range of 500–3000 is described by eq 4:
[A  2/A] 3  107Mr
1.9241(R2  0.9989) (4)
and the relative abundance of the naturally occurring
A  4 ion (A  4/A) over an Mr range of 1500–3000 is
described by eq 5:
[A  4/A]  2  1012Mr
3.2684(R2  0.9993) (5)
The lower molecular weight range for this curve was
limited to 1500 since the contribution to the A  4
channel by naturally occurring isotopes is less than 5%
below 1500 Da.
Eqs 4 and 5 were used to restate the abundances of
16O, 18O1, and
18O2 terms (eqs 1–3) as:
16O  [A]  (0.05 18O ) (6)118O1  [A 2]  (
16O  (3  107Mr
1.9241))
 (0.05 16O) (7)
18O2  [A 4]  (
18O1  (3  10
7Mr
1.9241))
 (16O  (2  1012Mr
3.2684)) (8)
Calculation of 16O/18O ratios for BSA and
Transferrin Tryptic Peptides
For calculation of 16O/18O ratios we made the reason-
able assumption that molar responses of the 16O and
18O peptides are equivalent, and that the 18O abundance
is described by the sum of ion abundances from the 18O1
and 18O2 species.
Figure 2a and b compares the results obtained using
averagine-based chemical formulas versus using se-
quence-specific molecular formulas to calculate 16O/
18O ratios for BSA (1 : 3 ratio) and transferrin (1 : 1 ratio)
for peptides identified by both tandem mass spectro-
metry and accurate mass measurements. The slope of
the lines indicate a strong correlation between the two
methods for calculating naturally occurring contribu-
tions to the A  2 and A  4 ion abundances; the data
are described by the lines y  0.983X  0.0022, R2 
0.998 for BSA (16O/18O ratio of 0.33) and y  0.965X 
0.0053, R2  0.997 for transferrin (16O/18O ratio of 1.0).
From the slope of each line, we can see that using
averagine to calculate A  2 relative abundance gave
16O/18O ratios within 5% of ratios obtained when
naturally occurring A  2 and A  4 ratios were
calculated using their specific amino acid sequence.
Using a 99% confidence interval, the y-intercepts for
both BSA and transferrin pass through the origin.
Moreover, the deviations did not appear to be biased as
a function of peptide molecular weight or 18O1/
18O2
ratio (data not shown).
For BSA, the mean 16O/18O ratio obtained from 26
peptides was 0.36  0.09 (CIM99%). For transferrin, the
mean 16O/18O ratio obtained from 32 peptides was 1.48
 0.47 (CIM99%). For each protein, the mean value the
confidence interval of the mean at the 99% confidence
interval, contained the expected relative expression
ratio. In addition, Figure 2c and d show that most of the
deviation of ion ratios from the accepted value occurred
at lower ion abundances. When the transferrin data set
is recalculated for all data points with ion abundance
greater than an arbitrary value of 1.0, the mean 
CIM99% is 1.25  0.32.
To further characterize the ability of averagine to
calculate naturally occurring contributions to the A  2
and A  4 ion abundances, we simulated composite
16O/18O1/
18O2 spectra for tryptic peptides from BSA
and transferrin. Initially, naturally occurring isotope
abundances were calculated from peptide sequences
with molecular weights of approximately 1000, 1500,
and 2500 using the isotope modeling tool of the Micro-
mass software (MassLynx version 4.0). Isotope distribu-
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18O2-labeled equivalents were then
created by duplicating the relative abundances of the
naturally occurring isotopes shifted by 2 and 4 mass
units. Composite spectra were created by summing the
channels contributed by the 16O, 18O1, and
18O2 isotope
distributions.
Additionally, the relative abundances of the 16O,
18O1, and
18O2 isotope distributions were scaled using
two input parameters: The first parameter specified the
overall 16O/18O ratio, and the second parameter varied
the relative abundance of the 18O1 and
18O2 forms for
the heavy sample. An example is shown in Figure 3 for
the transferrin tryptic peptide YLGEEYVK, ([M H]
 1000.503, C47H69N9O15) using a
16O/18O ratio of 1.0
and a fractional value of 0.5 for the 18O1 abundance (i.e.,
a 1:1 distribution between 18O1 and
18O2). We tested our
averagine-based method for calculating 16O/18O ratios
against composite spectra generated from sequences at
molecular weight ranges from 1000 to 2500 mass units.
The 16O/18O ratio was varied from 0.1 to 10, while
using fractional values of 1, 0.5, and 0 for the relative
abundance of 18O1 versus
18O2.
The data in Figure 4 summarizes errors in 16O/18O
ratios that are introduced by averagine-based empirical
formulas solely based on molecular weight. The relative
error (the percent difference between calculated values
and prescribed values) varied between 0 and 35% over
Figure 2. Plot of 16O/18O ion ratios calculated u
formulas (x-axis) for (a) BSA and (b) transferrin;
abundance (amplitude) for (c) BSA and (d) trans
ratios for these proteins (  0.33 for BSA andthe range of molecular weights that were tested. From
this data the greatest errors were observed when the
16O/18O ratio is substantially greater than 1, since it is
more difficult to discern small additions to the A  2 or
averagine (Y-axis) versus from specific chemical
16O/18O ion ratios measured plotted versus ion
. The dashed lines depict the expected 16O/18O
r transferrin).
Figure 3. A composite 16O/18O spectrum formed from relative
isotope abundances calculated for C47H69N9O15, the chemical
formula for the tryptic peptide YLGEEYVK, ([M  H] 
1000.503, C47H69N9O15). The composite spectrum was formed
using a 16O/18O ratio of 1.0 and a 18O1/
18O2 distribution of 0.5
(18O1/(
18O1
18O2)) as shown in the inset table. The calculated
16O/18O ratio using our averagine-based method was 0.987, a
1.3% error from actual.sing
and
ferrin
1.0 fo
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is optimally applied to the sample state where informa-
tion on up-regulated proteins is being sought (e.g., for
disease biomarker discovery, the 18O label would pref-
erentially be applied to the diseased sample rather than
the control).
Another source of significant error occurs when the
number of sulfur atoms from cysteine or methionine
residues differs from the number of sulfur atoms pre-
dicted by averagine. Using averagine to generate rep-
resentative chemical formulas for peptides based only
on peptide molecular weight, the transition from zero
sulfur atoms to one sulfur atom occurs at approximately
1335 Da; this point of sulfur incorporation is observed
in Figure 1b as an inflection in the A  2 curve between
1250 and 1500 Da.
For example, if the calculated 16O/18O ratio is 5,
and there is a mismatch of one sulfur atom between the
averagine model and actual peptide sequence, an ap-
proximate error of 20% will be introduced into the
16O/18O ratio; if the 16O/18O ratio is less than one, the
relative error decreases to less than 10%. The largest
errors will occur for peptides at lower mass containing
two sulfur atoms. As an extreme example, the BSA
peptide CCAADDK, 838 Da (as carbamidomethylated
cysteines), and containing two sulfur atoms, incurs an
error of 42% for a 16O/18O ratio of 10 and when all of
the 18O label is expressed as 18O . However, for a
Figure 4. Plot of relative errors incurred using
peptides, as a function of 16O/18O ratio, peptide
series are described in the table by peptide seq
versus the sulfur content predicted by averagine
varying the distribution between 18O1 and
18O2.116O/18O ratio of 1.0, the error ranges from 10–12%; and
even at a 16O/18O value of 3, the error is 19–21%
depending on 18O1/
18O2 distribution. These errors are
in the same range of uncertainties that have been
reported for the ICAT method [26].
Yao et al, have recently reported a method to drive
proteolysis toward a complete incorporation of two
molecules of 18O [19], and have also demonstrated the
effectiveness of the labeling method for a low molecular
weight fraction of serum [27]. While there may be an
advantage to incorporate two molecules of 18O in anal-
yses where isotopes are not fully resolved, the distribu-
tion between 18O1 and
18O2 introduces less error into the
overall 16O/18O ratio calculation than when the ratio is
greater than 3, or when mis-estimation of sulfur content
occurs.
Even with complete incorporation of 18O2, a need for
calculating contributions from naturally occurring
isotopes still exists when one considers that peptides
with molecular weight of 2000 have a naturally
occurring A  4/A ratio of 0.12; and for a 2500 mass
unit peptide, the naturally occurring A  4/A ratio
increases to 0.26.
Conclusions
We have described a method for the putative
identification and relative quantification of protein
ragine to calculate 16O/18O ion ratios for eight
cular weight and sulfur content. The eight data
e, molecular weight, and actual sulfur content
series A shows the relative error introduced byave
mole
uenc
. Data
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mass tags and stable isotope labeled ion ratios gen-
erated from nLC-dual ESI-FT-ICR-MS to calculate
16O/18O ratios without prior knowledge of amino
acid composition of the peptides being quantified.
This allows comprehensive differentiation of expres-
sion levels by 16O/18O ratios, and tentative peptide
identification using accurate mass tags, followed by
targeted tandem mass spectrometry on peptides of
interest wherein the accurate mass tag does not result
in a unique protein identification. Using a model
system consisting of BSA and transferrin, we ob-
tained a mean MMA of 1.9 ppm 0.94 ppm (CIM99%,
n  58) on a 7T instrument. The same data set gave a
mean 16O/18O ratio of 0.36  0.09 (CIM99%) for 26
peptides from BSA (  0.33) and 1.48  0.47
(CIM99%) for 32 peptides from transferrin (  1.0).
Our data suggests that in the context of detecting
proteins with elevated relative expression levels,
such as in biomarker discovery, there is an advantage
to labeling the disease sample with the 18O label and
the control sample with 16O. The use of averagine-
based calculations to estimate naturally occurring
isotopes should also prove effective for other isotope-
coded experiments where overlapping isotopic distri-
butions are present.
While we are pursuing the use of FT-ICR-MS for
the discovery of biomarkers because of the tech-
nique’s advantages in sensitivity, mass resolving
power, mass measurement accuracy, and dynamic
range, the method reported here for calculating
16O/18O ratios is also applicable to data from any
mass analyzer capable of resolving and accurately
recording the abundances of the contributing iso-
topes.
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